Nuclear medicine diagnosis of bone metastases;Nuklearmedizinische diagnostik von knochenmetastasen

Praxis

Volumn 98, Issue 22, 2009, Pages 1293-1297

  Strobel, Klaus ^a  

^a LUZERNER KANTONSSPITAL   (Switzerland)

Author keywords

Bone metastases; PET CT; Scintigraphy; SPECT CT

Indexed keywords

FLUORIDE; FLUORODEOXYGLUCOSE F 18;

BONE METASTASIS; BONE SCINTISCANNING; BREAST CANCER; CANCER RISK; HUMAN; PROSTATE CANCER; SHORT SURVEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 70449584599     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/1661-8157.98.22.1293     Document Type: Short Survey

References (10)

1. Strobel, K., et al., Characterization of Focal Bone Lesions in the Axial Skeleton: Performance of Planar Bone Scintigraphy Compared with SPECT and SPECT Fused with CT. AJR Am J Roentgenol, 2007. 188(5): p.W467-74.
2. Utsunomiya, D., et al., Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT. Radiology, 2006. 238(1): p. 264-71. (Pubitemid 43010604)
3. Romer, W., et al., SPECT-Guided CT for Evaluating Foci of Increased Bone Metabolism Classified as In determinate on SPECT in Cancer Patients. J Nucl Med, 2006. 47(7): p. 1102-6. (Pubitemid 47544905)
4. Cook, G.J., et al., Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol, 1998. 16(10): p. 3375-9. (Pubitemid 28481635)
5. Song, J.W., et al., Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bonymetastases of non-small-cell lung cancer. Lung Cancer, 2009.
6. Specht, J.M., et al., Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) tomonitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP). Breast Cancer Res Treat, 2007. 105(1): p. 87-94. (Pubitemid 47282751)
7. Klaeser, B., et al., Therapeutic impact of 2-[fluorine-18]fluoro-2-deoxy- D-glucose positron emission tomography in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer. Ann Oncol, 2007. 18(8): p. 1329-34. (Pubitemid 47305005)
8. Carkaci, S., et al., Retrospective Study of 18F-FDG PET/CT in the Diagnosis of Inflammatory Breast Cancer: Preliminary Data. J Nucl Med, 2009. 50(2): p. 231-238.
9. Grant, F.D., et al., Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med, 2008. 49(1): p. 68-78.
10. Even-Sapir, E., et al., The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med, 2006. 47(2): p. 287-97. (Pubitemid 46780894)